USPTO serial 88730128
TRUSIGHT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 28, 2025
- Examiner
- LIU, PHILIP HUAI-EN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TRUSIGHT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan M. Natland
Susan M. Natland Baker & Hostetler LLP600 Anton Blvd, Suite 900Costa Mesa, CA 92626-7221United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents, enzymes, and nucleotides for scientific or medical research use; Reagents, enzymes, and nucleotides for nucleic acid sequencing other than for medical and veterinary purposes; biological agents, reagents, assays, enzymes, nucleotides, buffers for analytical chemistry for use in science and scientific research, chemical preparations, and biological preparations for scientific and research use; Diagnostic reagents and preparations, other than for medical or veterinary use; Kits containing chemical reagents for use thereof for non- medical science and research purposes; biological agents, reagents, assays, enzymes, nucleotides, buffers for analytical chemistry, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics, not for medical or veterinary purposes; Kits comprising nucleotides, reagents, enzyme substrates, buffers for analytical chemistry, chemical preparations, and biological preparations for scientific and research use including in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics, not for medical or veterinary purposes | ACTIVE | — |
| 005 | Reagents, enzymes, and nucleotides for nucleic acid sequencing for medical purposes; Biological diagnostic agents, reagents, medical diagnostic assays, enzymes, nucleotides for medical purposes, and buffers for disease testing, for medical use and diagnostic purposes in the fields of nucleic acid sequencing, genotyping, diagnostic research, clinical research, medical laboratory research, veterinary science and research, genetics, agriculture, and metagenomics; Diagnostic reagents and preparations for medical and veterinary use; Kits containing reagents for use thereof for medical and diagnostic purposes in the fields of nucleic acid sequencing, genotyping, diagnostic research, clinical research, medical laboratory research, veterinary science and research, genetics, agriculture, and metagenomics; kits comprised of nucleotides for medical purposes, reagents, medical diagnostic assays, and buffers for disease testing, for medical genetic testing and medical diagnostic purposes in the fields of nucleic acid sequencing, genotyping, diagnostic research, clinical research, medical laboratory research, veterinary science and research, genetics, agriculture, and metagenomics, and enzyme substrates; Biological agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical and veterinary use in the fields of medical diagnostics, clinical diagnostics, veterinary diagnostics, medical forensics, laboratory medicine, veterinary medicine, genetic testing, and genetics | ACTIVE | — |
| 009 | Laboratory devices for detecting genetic sequences; Diagnostic apparatus for the detection of pathogens for laboratory or research use; Scientific apparatus and instruments, namely, laboratory devices for detecting genetic sequences for use in genetic analysis; Apparatus for DNA and RNA testing for research and scientific purposes; Apparatus and instruments, namely, l aboratory devices for detecting genetic sequences for testing gases, liquids, and solids in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostics, clinical research, drug development, pharmaceuticals, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, genetic testing, and genetics; DNA chips; data processing apparatus not used to calculate and report website traffic statistics; Computers; Computer monitors; computer hardware not used to calculate and report website traffic statistics; Computer hardware and downloadable and recorded computer software for use in data analysis in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, genetic testing and genetics; Micro-processors; Data processors not used to calculate and report website traffic statistics; Nextgeneration sequencing bioinformatics data processor; Cards with integrated circuits; Computer chips; Encoded electronic chip cards containing programming used for DNA sequencing; downloadable computer application software for mobile phones, portable media players, handheld computers, tablet computers, and computers, namely, software to receive and store DNA and genetic records, and to authorize medical and research personnel to use records; Downloadable electronic publications in the nature of articles and reports in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, medical diagnostics, clinical diagnostics, veterinary diagnostics, medical forensics, laboratory medicine, veterinary medicine, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics; Downloadable reports in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, medical diagnostics, clinical diagnostics, veterinary diagnostics, medical forensics, laboratory medicine, veterinary medicine, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics | ACTIVE | — |
| 041 | Providing online non-downloadable electronic publications in the nature of articles and magazines in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, medical diagnostics, clinical diagnostics, veterinary diagnostics, medical forensics, laboratory medicine, veterinary medicine, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics; Providing online non-downloadable reports in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, medical diagnostics, clinical diagnostics, veterinary diagnostics, medical forensics, laboratory medicine, veterinary medicine, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics | ACTIVE | — |
| 042 | Genetic DNA and RNA analysis in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, medical diagnostics, clinical diagnostics, veterinary diagnostics, medical forensics, laboratory medicine, veterinary medicine, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics for scientific and research purposes; Nucleic acid sequencing and analysis services for scientific and research purposes; Providing on-line non-downloadable computer search engine software for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, genetic testing and genetics; providing online non-downloadable computer software for the custom design and ordering of assays, nucleic acids and reagents; Software as a service (SaaS), namely, hosting software for use by others for use in the custom design and ordering of assays, nucleic acids and reagents in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics; Nucleic acid sequencing and analysis services for scientific and research purposes; Genome sequencing and analysis services for scientific and research purposes; genetic DNA and RNA analysis and reporting services in the nature of computer reports in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, medical diagnostics, clinical diagnostics, veterinary diagnostics, medical forensics, laboratory medicine, veterinary medicine, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology and metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics for scientific and research purposes; installation and maintenance of computer software and database applications for others for use in the fields of nucleic acid sequencing and genotyping, medical diagnostics, clinical diagnostics, medical research, clinical research, life sciences, biology, drug development, drug development research, molecular diagnostics, laboratory medicine, biotechnology, agriculture, forensics, and genetics; Clinical diagnostics in the nature of conducting clinical trials for others and consultation services in the fields of nucleic acid sequencing and genotyping, medical research, veterinary medical research, clinical research, pharmaceutical drug development, medical laboratory research, veterinary laboratory and medical research services, biological research, microbiology research, biotechnology research, agricultural chemistry, forensic science, food safety testing, metagenomics, and genetic testing for scientific research purposes; Scientific laboratory services; Medical laboratory services; Computer services, namely, cloud hosting provider services and onsite provider services in the nature of onsite management of information technology (IT) systems of others that allows users to store, analyze and share information over a global computer network in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics; Providing an online network service, namely, providing an online network environment that features technology that enables users to store, access, manage, analyze and share data for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, veterinary diagnostics, clinical diagnostics, medical research, veterinary research, diagnostic research, clinical research, drug development, drug development research, medical laboratory research, veterinary science and research, life sciences, biology, microbiology, biotechnology, agriculture, forensics, food safety, metagenomics, and genetics; Design and development of automated laboratory apparatus, laboratory equipment, and computer systems for others; Proof of concept services for others, namely, scientific consulting and technical consulting and research services in the field of clinical experiment design, library quality control for others, tracking of samples for others, sample quality control for others; Design and preparation of databases in the nature of database development services for others for collecting, storing, analyzing, and reporting biological information; Rental of laboratory equipment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Illumina, Inc.
- Other trademarks owned by Illumina, Inc.
- Other trademarks owned by Illumina, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named TRUSIGHT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 29, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 29, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 29, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 29, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 29, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 29, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 28, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 28, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 3, 2025 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jan 3, 2025 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Dec 2, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 2, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 2, 2024 | ALIE | ASSIGNED TO LIE | — |
| Oct 10, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 12, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2024 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 5, 2024 | IUAF | USE AMENDMENT FILED | — |
| Jun 5, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 5, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jun 5, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 5, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 5, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 15, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 14, 2023 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Dec 13, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 5, 2023 | EXT5 | SOU EXTENSION 5 FILED | — |
| Dec 5, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 2, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 31, 2023 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 31, 2023 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 31, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 9, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 7, 2022 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 7, 2022 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 7, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 9, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 7, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 7, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 7, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 8, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 6, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 6, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 6, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 8, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 13, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 13, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 24, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 5, 2021 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Mar 5, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 2, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 2, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 26, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 26, 2021 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Feb 26, 2021 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Feb 26, 2021 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Aug 26, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 26, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 26, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 6, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 8, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 25, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 6, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 30, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 20, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 20, 2019 | NWAP | NEW APPLICATION ENTERED | — |